26/February/2022 Top Medical Bulletin Dr. Nandita Mohan26 Feb 2022 5:37 PM ISTHere are top medical stories for the dayWeight fluctuations increase cardiovascular and mortality risk in type 2 diabetes patients Fat and...
Lowering Glucose levels reduces complication risk in diabetes patients with ASCVD Dr. Nandita Mohan24 Feb 2022 7:45 PM ISTDiabetes is a severe metabolic disorder in several people its the root cause of many chronic diseases. In individuals with diabetes, atherosclerotic...
Weight fluctuations increase cardiovascular and mortality risk in type 2 diabetes patients: JAMA Medical Dialogues Editorial Team24 Feb 2022 10:00 AM ISTUSA: In a new study conducted by Arnaud D. Kaze and team it was found that higher variability of adiposity indices was related to a substantially...
SGLT2 inhibitor dapagliflozin may prevent cardiovascular complications in type 1 diabetes: Study Medha Baranwal23 Feb 2022 9:45 AM ISTBudapest, Hungary: Recent data published in PLOS One supports the preventive and protective role of SGLT2 inhibitors in cardiovascular disease (CVD)...
Statin intolerance is "over-estimated and over-diagnosed" Hina Zahid18 Feb 2022 9:45 AM ISTAs many as one in two patients stop taking statins, reduce the dose or take them irregularly because they believe the cholesterol-lowering drugs cause...
Improving models to predict cardiovascular disease in individuals with kidney dysfunction Hina Zahid16 Feb 2022 9:00 AM ISTWashington, DC - A new study reveals that certain changes to models that predict the risk of developing cardiovascular problems in the general...
Stroke occurrence linked to familial history Dr. Nandita Mohan15 Feb 2022 5:40 PM ISTstroke is the second leading cause of death world wide however its management is a growing burden as reoccurences are most common in the past decade...
Modest folate-intake improves of long-term survival of adults at high-risk of CVD: Study Medha Baranwal14 Feb 2022 9:00 AM ISTChina: A recent study has found that modest folate intake may improve long-term survival in adults at high risk of cardiovascular disease (CVD) and...
Orion – 4 trial: Inclisiran effective in reducing cholesterol Dr. Nandita Mohan12 Feb 2022 11:04 AM ISTInclisiran is a popular drug, studied for its effect to control bad cholesterol or LDL levels in blood, a proprotein convertase subtilisin/kexin type...
DAPA CKD Trial: Dapaglifloxin to improve diabetic nephropathy Dr. Nandita Mohan11 Feb 2022 6:56 PM IST Diabetic nephropathy is a serious complication of type 1 diabetes and type 2 diabetes. It's also called diabetic kidney disease. In the United...
Ras inhibitors affects kidney vessels to greater extent Dr. Nandita Mohan8 Feb 2022 5:42 PM ISTHypertension treatment is resulting in blood flow obstruction, focal ischemia, and fibrosis in kidney vessels. Study conducted on rats said that...
Anacetrapib with statins to lower atherosclerotic heart disease Dr. Nandita Mohan3 Feb 2022 8:00 AM ISTAtherosclerotic cardiovascular diseases are the largest cause of morbidity and premature death worldwide. REVEAL trial in the European Heart Journal...
